Neuromodulation News and Research

RSS
Greatbatch second quarter 2012 sales increase 14% to $166.5 million

Greatbatch second quarter 2012 sales increase 14% to $166.5 million

Neurotech’s ADNS-300 system obtains European CE Mark approval

Neurotech’s ADNS-300 system obtains European CE Mark approval

NYU Langone establishes unique neuromodulation center

NYU Langone establishes unique neuromodulation center

Medtronic fourth quarter revenue increases 4% to $4.297 billion

Medtronic fourth quarter revenue increases 4% to $4.297 billion

AUA includes percutaneous tibial nerve stimulation in OAB treatment guidelines

AUA includes percutaneous tibial nerve stimulation in OAB treatment guidelines

FDA clears Bioness smaller leg cuff for use with L300 Foot Drop System

FDA clears Bioness smaller leg cuff for use with L300 Foot Drop System

Results reported for clinical trial for the treatment of depression using external trigeminal nerve stimulation

Results reported for clinical trial for the treatment of depression using external trigeminal nerve stimulation

Neurosurgeons from NYU Langone to present at AANS annual meeting

Neurosurgeons from NYU Langone to present at AANS annual meeting

Bioness commences StimRouter Neuromodulation System study for chronic peripheral nerve pain

Bioness commences StimRouter Neuromodulation System study for chronic peripheral nerve pain

Patients with tinnitus may soon have a definitive therapy

Patients with tinnitus may soon have a definitive therapy

Study tests new method of sound simulation for treating tinnitus

Study tests new method of sound simulation for treating tinnitus

SBMT announces 2012 recipients of Pioneers in Medicine, Technology and Healthcare Policy Awards

SBMT announces 2012 recipients of Pioneers in Medicine, Technology and Healthcare Policy Awards

Enrollment commences in MORE Registry for DBS in patients with refractory epilepsy

Enrollment commences in MORE Registry for DBS in patients with refractory epilepsy

Health Canada grants license to Medtronic DBS Therapy for refractory epilepsy

Health Canada grants license to Medtronic DBS Therapy for refractory epilepsy

ROSETTA Study to compare two therapies in women with overactive bladder

ROSETTA Study to compare two therapies in women with overactive bladder

Tenfold increase in OARnet network bandwidth speeds will boost medical research

Tenfold increase in OARnet network bandwidth speeds will boost medical research

ATI commences European trial of neurostimulation system for migraine

ATI commences European trial of neurostimulation system for migraine

Greatbatch acquires NeuroNexus

Greatbatch acquires NeuroNexus

St. Jude Medical fourth quarter net sales increase 4% to $1.407B

St. Jude Medical fourth quarter net sales increase 4% to $1.407B

DBS safe and effective for patients with advanced Parkinson's

DBS safe and effective for patients with advanced Parkinson's